174 related articles for article (PubMed ID: 33975030)
1. Control of Intestinal Epithelial Permeability by Lysophosphatidic Acid Receptor 5.
Wang M; He P; Han Y; Dong L; Yun CC
Cell Mol Gastroenterol Hepatol; 2021; 12(3):1073-1092. PubMed ID: 33975030
[TBL] [Abstract][Full Text] [Related]
2. Expression of lysophosphatidic acid receptor 5 is necessary for the regulation of intestinal Na
Jenkin KA; He P; Yun CC
Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G433-G442. PubMed ID: 29792531
[TBL] [Abstract][Full Text] [Related]
3. LPA
McConnell BB; Liang Z; Xu C; Han Y; Yun CC
Am J Physiol Gastrointest Liver Physiol; 2024 Jun; 326(6):G631-G642. PubMed ID: 38593468
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic Acid Receptor 1 Is Important for Intestinal Epithelial Barrier Function and Susceptibility to Colitis.
Lin S; Han Y; Jenkin K; Lee SJ; Sasaki M; Klapproth JM; He P; Yun CC
Am J Pathol; 2018 Feb; 188(2):353-366. PubMed ID: 29128569
[TBL] [Abstract][Full Text] [Related]
5. Survival of Stem Cells and Progenitors in the Intestine Is Regulated by LPA
Liang Z; He P; Han Y; Yun CC
Cell Mol Gastroenterol Hepatol; 2022; 14(1):129-150. PubMed ID: 35390517
[TBL] [Abstract][Full Text] [Related]
6. Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA
Minami K; Ueda N; Maeda H; Ishimoto K; Otagaki S; Tsujiuchi T
Biochem Biophys Res Commun; 2019 Sep; 517(2):359-363. PubMed ID: 31362892
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of lysophosphatidic acid receptor-5 on cellular functions of sarcoma cells.
Araki M; Kitayoshi M; Dong Y; Hirane M; Ozaki S; Mori S; Fukushima N; Honoki K; Tsujiuchi T
Growth Factors; 2014 Jun; 32(3-4):117-22. PubMed ID: 24798396
[TBL] [Abstract][Full Text] [Related]
8. Compensatory Upregulation of LPA
Liang Z; Yun CC
Cells; 2022 Jul; 11(14):. PubMed ID: 35883686
[TBL] [Abstract][Full Text] [Related]
9. Sodium absorption stimulator prostasin (PRSS8) has an anti-inflammatory effect via downregulation of TLR4 signaling in inflammatory bowel disease.
Sugitani Y; Nishida A; Inatomi O; Ohno M; Imai T; Kawahara M; Kitamura K; Andoh A
J Gastroenterol; 2020 Apr; 55(4):408-417. PubMed ID: 31916038
[TBL] [Abstract][Full Text] [Related]
10. LPAR2 receptor activation attenuates radiation-induced disruption of apical junctional complexes and mucosal barrier dysfunction in mouse colon.
Shukla PK; Meena AS; Gangwar R; Szabo E; Balogh A; Chin Lee S; Vandewalle A; Tigyi G; Rao R
FASEB J; 2020 Sep; 34(9):11641-11657. PubMed ID: 32654268
[TBL] [Abstract][Full Text] [Related]
11. Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice.
Zhao H; Zhang H; Wu H; Li H; Liu L; Guo J; Li C; Shih DQ; Zhang X
BMC Gastroenterol; 2012 May; 12():57. PubMed ID: 22647055
[TBL] [Abstract][Full Text] [Related]
12. LPA
Minami K; Ueda N; Ishimoto K; Tsujiuchi T
Exp Cell Res; 2020 Mar; 388(1):111813. PubMed ID: 31904382
[TBL] [Abstract][Full Text] [Related]
13. Role of lysophosphatidic acid in proliferation and differentiation of intestinal epithelial cells.
Konno T; Kotani T; Setiawan J; Nishigaito Y; Sawada N; Imada S; Saito Y; Murata Y; Matozaki T
PLoS One; 2019; 14(4):e0215255. PubMed ID: 31017922
[TBL] [Abstract][Full Text] [Related]
14. LPA5 is abundantly expressed by human mast cells and important for lysophosphatidic acid induced MIP-1β release.
Lundequist A; Boyce JA
PLoS One; 2011 Mar; 6(3):e18192. PubMed ID: 21464938
[TBL] [Abstract][Full Text] [Related]
15. Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain.
Lin ME; Rivera RR; Chun J
J Biol Chem; 2012 May; 287(21):17608-17617. PubMed ID: 22461625
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Hexadecyl-LPA-Mediated Activation of Mast Cells and Microglia by a Chemical Probe for LPA5.
Kozian DH; von Haeften E; Joho S; Czechtizky W; Anumala UR; Roux P; Dudda A; Evers A; Nazare M
Chembiochem; 2016 May; 17(9):861-5. PubMed ID: 26812365
[TBL] [Abstract][Full Text] [Related]
17. PGI
Pochard C; Gonzales J; Bessard A; Mahe MM; Bourreille A; Cenac N; Jarry A; Coron E; Podevin J; Meurette G; Neunlist M; Rolli-Derkinderen M
Cell Mol Gastroenterol Hepatol; 2021; 12(3):1037-1060. PubMed ID: 33971327
[TBL] [Abstract][Full Text] [Related]
18. Syndecan-1 Acts in Synergy with Tight Junction Through Stat3 Signaling to Maintain Intestinal Mucosal Barrier and Prevent Bacterial Translocation.
Wang Z; Li R; Tan J; Peng L; Wang P; Liu J; Xiong H; Jiang B; Chen Y
Inflamm Bowel Dis; 2015 Aug; 21(8):1894-907. PubMed ID: 25970544
[TBL] [Abstract][Full Text] [Related]
19. Intestinal Epithelial Expression of MHCII Determines Severity of Chemical, T-Cell-Induced, and Infectious Colitis in Mice.
Jamwal DR; Laubitz D; Harrison CA; Figliuolo da Paz V; Cox CM; Wong R; Midura-Kiela M; Gurney MA; Besselsen DG; Setty P; Lybarger L; Bhattacharya D; Wilson JM; Ghishan FK; Kiela PR
Gastroenterology; 2020 Oct; 159(4):1342-1356.e6. PubMed ID: 32589883
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function.
Cario E; Gerken G; Podolsky DK
Gastroenterology; 2007 Apr; 132(4):1359-74. PubMed ID: 17408640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
